future glp-1 drugs What to Make of the Coverage and Cost Landscape GLP-1 Drugs: Fighting Diabetes and

Description

Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety

An extensive new study says GLP-1 drugs are 'not associated with an increased risk of thyroid cancer'

Pharmacokinetics of exenatide in nonhuman primates following its administration in the form of sustained-release PT320 and bydureon

An 8.7% reduction exceeds what most lifestyle interventions achieve

Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of alzheimers disease